NCT04221399View on ClinicalTrials.gov

Type 2 Diabetes Patients With Renal Impairment

PHASE1UnknownINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

January 31, 2020

Primary Completion Date

August 31, 2020

Study Completion Date

October 31, 2020

Conditions
Type2 Diabetes
Interventions
DRUG

DWP16001

Tablets, Oral, Once daily, Single dose

DRUG

DWP16001

Tablets, Oral, Once daily, Multiple dose

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY